A detailed history of Merit Financial Group, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Merit Financial Group, LLC holds 6,283 shares of ZTS stock, worth $1.15 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,283
Previous 9,320 32.59%
Holding current value
$1.15 Million
Previous $1.62 Million 24.02%
% of portfolio
0.03%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$172.58 - $196.48 $524,125 - $596,709
-3,037 Reduced 32.59%
6,283 $1.23 Million
Q2 2024

Aug 13, 2024

BUY
$145.54 - $178.83 $71,169 - $87,447
489 Added 5.54%
9,320 $1.62 Million
Q1 2024

May 06, 2024

BUY
$165.67 - $199.94 $882,192 - $1.06 Million
5,325 Added 151.88%
8,831 $1.49 Million
Q4 2023

Feb 06, 2024

SELL
$151.44 - $200.09 $575,926 - $760,942
-3,803 Reduced 52.03%
3,506 $691,000
Q3 2023

Nov 07, 2023

BUY
$167.14 - $192.77 $41,785 - $48,192
250 Added 3.54%
7,309 $1.27 Million
Q2 2023

Aug 01, 2023

BUY
$160.94 - $186.23 $488,774 - $565,580
3,037 Added 75.51%
7,059 $1.22 Million
Q1 2023

Apr 24, 2023

SELL
$145.48 - $175.02 $371,701 - $447,176
-2,555 Reduced 38.85%
4,022 $669,000
Q4 2022

Jan 13, 2023

BUY
$131.14 - $157.47 $247,592 - $297,303
1,888 Added 40.26%
6,577 $0
Q3 2022

Oct 31, 2022

SELL
$148.29 - $182.55 $626,673 - $771,456
-4,226 Reduced 47.4%
4,689 $695,000
Q2 2022

Aug 08, 2022

BUY
$155.97 - $200.09 $1.03 Million - $1.32 Million
6,573 Added 280.66%
8,915 $1.53 Million
Q1 2022

May 13, 2022

BUY
$181.39 - $234.03 $204,426 - $263,751
1,127 Added 92.76%
2,342 $442,000
Q4 2021

Feb 14, 2022

BUY
$193.69 - $247.03 $9,297 - $11,857
48 Added 4.11%
1,215 $297,000
Q2 2021

Aug 16, 2021

BUY
$155.9 - $187.99 $181,935 - $219,384
1,167 New
1,167 $217,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $85.5B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Merit Financial Group, LLC Portfolio

Follow Merit Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Merit Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Merit Financial Group, LLC with notifications on news.